Celldex (CLDX) Tops Q2 EPS by 1c

Celldex (NASDAQ: CLDX) reported Q2 EPS of ($0.65), $0.01 better than the analyst estimate of ($0.66). Revenue for the quarter came in at $270 thousand versus the consensus estimate of $528 thousand.

For earnings history and earnings-related data on Celldex (CLDX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Medtronic completes $550 million Scientia Vascular acquisition
• Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$221 at BMO Capital